A randomized, double-blind, placebo-controlled, parallel group multicenter study to investigate efficacy and safety of ITF 2357 in the management of patients with active moderate to severe Crohn’s disease A randomized, double-blind, placebo-controlled, parallel group multicenter study to investigate effi ...
A randomized, double-blind, placebo-controlled, parallel group multicenter study to investigate efficacy and safety of ITF 2357 in the management of patients with active moderate to severe Crohn’s disease A randomized, double-blind, placebo-controlled, parallel group multicenter study to investigate effi ...